跳至主要内容
临床试验/NCT02524496
NCT02524496已完成不适用

Limited Access, Open-label, Compassionate Use of Cisapride in the Treatment of Gastroparesis

Yale University0 个研究点目标入组 3 人开始时间: 2001年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3
主要终点
Improvement in gastric emptying via self-report

研究概览

简要总结

Due to the lack of other drugs to treat gastroparesis Janssen and FDA approved the compassionate use of cisapride to treat patients who had no other effective therapy. For this observational study, 3 patients who had already been prescribed cisapride by outside physicians, were followed to determine the effectiveness of cisapride on their gastric emtpying.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of gastroparesis.

排除标准

  • No diagnosis of gastroparesis.

结局指标

主要结局

Improvement in gastric emptying via self-report

时间窗: ten years

Patients were asked at clinical appointments about problems and improvement with gastric emptying.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验